Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Oxderys

Generic name: Doxorubicin hydrochloride

FDA application holder: Avyxa Holdings

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Oxderys?
Oxderys is a brand name of Doxorubicin hydrochloride, a prescription medicine. The FDA NDC Directory lists 2 Oxderys products in 1 strength and form.
Who makes Oxderys?
Avyxa Holdings holds the FDA application for Oxderys (NDA221093, approved November 9, 2026).
Is there a generic or store brand of Oxderys?
Yes. The FDA NDC Directory lists 27 other products with the same active ingredients, strength and form as a Oxderys product, 17 of them generic. Ask your pharmacist whether one is right for you.
Has Oxderys been recalled?
No recall linked to Oxderys products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Oxderys is

Each Oxderys product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Doxorubicin hydrochloride · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
doxorubicin hydrochloride 2 mg/mL
injection, solution (intravenous)
Oxderys 27 products, 7 companies —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Doxorubicin hydrochloride →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Oxderys products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA221093Avyxa HoldingsNovember 9, 20262

Companies that list Oxderys

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Oxderys products.

Recalls

No recall linked to Oxderys products (by their NDC code or label) appears in the FDA enforcement reports.

Next steps

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 11, 2026, retrieved November 14, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers